返回 Agenda
Session 6, Track 3: How to Make the Most of an Evolving Tech Landscape Crowded with Competing Solutions: Survival of the Fittest vs Symbiosis?
Session Chair(s)
Matthias Sijtstra
Senior Consultant
Main5 GmbH & Co. KGaA, Netherlands
This session will describe, differentiate and discuss the distinct approaches life sciences regulatory organizations have taken in acquiring, combining, and eliminating new innovative capabilities to optimize their digitalization journey. This session will include use cases from three different Life Sciences Companies of various sizes and illustrate their decision-making processes in evaluating, deploying, and managing digital capabilities. They will share their business needs, technical and process issues, design and decision-making frameworks, results, and key learnings.
A Tale of Two Use Cases: Lessons Learned and Way Forward in Combining Digital Capabilities Effectively - Salim Saglam, Genentech, Inc.
Digital Navigation: Selecting the Optimal Solution for Business Success - Jason Moyer, Gilead
Smart Choices: Decision-Making Frameworks for Digital Capability Integration - Jessica Romero, Sarepta Therapeutics
Learning Objective : At the conclusion of this session, participants should be able to:- Differentiate and assess strategic approaches for digitalization in life sciences
- Apply decision-making frameworks to tech evaluation
- Address challenges in digital adoption with limited resources
Speaker(s)
Digital Navigation: Selecting the Optimal Solution for Business Success
Jason Moyer, MBA
Gilead Sciences, Inc., United States
Executive Director Reg Affairs Innovation, Digital & External Partnerships
A Tale of Two Use Cases: Lessons Learned and Way Forward in Combining Digital Capabilities Effectively
Salim Saglam, MBA
Genentech, A Member of the Roche Group, United States
Director & Business Transformation Lead, Product Development
Smart Choices: Decision-Making Frameworks for Digital Capability Integration
Jessica Romero
Sarepta Therapeutics, United States
Director, Global Regulatory Operations, Global Regulatory Affairs